LSA
PRCT icon

Leonteq Securities AG’s Procept Biorobotics PRCT Stock Holding History

Leonteq Securities AG’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.31K Hold
191
– – ﹤0.01% 1104
2026
Q1 		$4.78K Hold
191
– – ﹤0.01% 1126
2025
Q4 		$6.01K Buy
191
+155
+431% +$5.14K ﹤0.01% 1236
2025
Q3 		$1.28K Hold
36
– – ﹤0.01% 1242
2025
Q2 		$2.07K Hold
36
– – ﹤0.01% 1174
2025
Q1 		$2.11K Hold
36
– – ﹤0.01% 1141
2024
Q4 		$2.9K Hold
36
– – ﹤0.01% 1140
2024
Q3 		$2.88K Buy
36
+1
+3% +$71 ﹤0.01% 1081
2024
Q2 		$2.14K Buy
+35
New +$2.08K ﹤0.01% 1098
2023
Q2 		– Sell
-1,836
Closed -$52.1K – 1297
2023
Q1 		$52.1K Hold
1,836
– – ﹤0.01% 791
2022
Q4 		$76.3K Buy
1,836
+624
+51% +$26.8K ﹤0.01% 728
2022
Q3 		$50.3K Buy
+1,212
New +$48.3K ﹤0.01% 806

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Leonteq Securities AG's PRCT Position: Q2 2026 in Review

Leonteq Securities AG held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 191 shares worth $4.31K. The position accounts for ﹤0.01% of the portfolio, ranked #1104.

Leonteq Securities AG first reported a position in PRCT in Q3 2022 and has held it in 12 quarters since. The position peaked at $76.3K in Q4 2022. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • Leonteq Securities AG held 191 shares of Procept Biorobotics worth $4.31K as of Q2 2026.
  • Leonteq Securities AG left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up ﹤0.01% of Leonteq Securities AG's portfolio in Q2 2026, its #1104 holding.
  • Leonteq Securities AG first reported a position in Procept Biorobotics in Q3 2022 and has held it in 12 quarters since.
  • Leonteq Securities AG's Procept Biorobotics position peaked at $76.3K in Q4 2022.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on Leonteq Securities AG's 13F filing for Q2 2026, filed 27 Jul 2026.